|1.||Jorge, Salomão Dória: 2 articles (10/2014 - 06/2013)|
|2.||Ferreira, Adilson Kleber: 2 articles (10/2014 - 06/2013)|
|3.||Cerecetto, Hugo: 2 articles (01/2014 - 12/2005)|
|4.||González, Mercedes: 2 articles (01/2014 - 12/2005)|
|5.||Chung, Man Chin: 1 article (01/2015)|
|6.||Bosquesi, Priscila Longhin: 1 article (01/2015)|
|7.||Travassos, L R: 1 article (01/2015)|
|8.||Marcondes, Sisi: 1 article (01/2015)|
|9.||Girola, N: 1 article (01/2015)|
|10.||Figueiredo, C R: 1 article (01/2015)|
|1.||Melanoma (Melanoma, Malignant)
01/01/2015 - "Benzofuroxan N-Br and N-I derivatives were active against murine and human tumor cell lines, exerting significant protection against metastatic melanoma in a syngeneic model. "
01/01/2015 - "B16F10-Nex2 melanoma cells were used to investigate the antitumor effects of Benzofuroxan derivatives in vitro and in a syngeneic melanoma model in C57Bl/6 mice. "
01/01/2015 - "In the present work, we evaluated the antitumor effects of different benzofuroxan derivatives in a murine melanoma model. "
01/01/2015 - "Benzofuroxan derivatives N-Br and N-I induce intrinsic apoptosis in melanoma cells by regulating AKT/BIM signaling and display anti metastatic activity in vivo."
|2.||Chagas Disease (American Trypanosomiasis)
06/01/2013 - "A set of substituted-[N'-(benzofuroxan-5-yl)methylene]benzohydrazides (4a-t), previously designed and synthesized, was experimentally assayed against Trypanosoma cruzi, the etiological agent of Chagas' disease, one of the most neglected tropical diseases. "
12/01/2005 - "Benzofuroxan derivatives have been shown to inhibit the growth of Trypanosoma cruzi, the etiological agent of Chagas' disease. "
01/01/2014 - "Specifically, benzofuroxan system seems to be responsible for the mutagenicity of certain agents against Chagas disease and certain anti-inflammatory agents. "
01/01/2011 - "Here we report the identification of a benzofuroxan derivative [7-(4-methylpiperazin-1-yl)-4-nitro-1-oxido-2,1,3-benzoxadiazol-1-ium, NSC207895] that could inhibit MDMX expression in cancer cells through a reporter-based drug screening. "
10/01/2014 - "Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells."
|3.||Anti-Inflammatory Agents (Anti-Inflammatories)
|4.||sorafenib (BAY 43-9006)